Neurologic Complications in Adult Hematologic Malignancies in Songklanagarind Hospital : Prevalence and Clinical Patterns

Authors

  • Veerakiat Leelarodjalek Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University
  • Arnuparp Lekhakula Department of Medicine, Faculty of Medicine, Prince of Songkla University

Keywords:

Neurologic complications, Hematologic malignancies, Prevalence, Clinical patterns, Meningeal involvement, Retrospective study

Abstract

Abstract : Objectives : To determine the prevalence and clinical features of neurologic complications in aquit patients with hematologic malignancies; and to identity the association between types of malignancies and clinical patterns of neurologic complications. Study design : Retrospective descriptive study Setting : Single center, Songklanagarind University Hospital
Materials and methods : Adult patients(age > 15 years) with the diagnosis of leukemia, Iymphoma and multiple myeloma admitted during January 1987 and December 19996. The diagnosis of neurologic complications was based on clinical manifestations and additional laboratory investigations The data extracted for medical records included age, sex, type of malignancy, stage of disease, neurological symptoms and signs, additional investigations, treatment and result. Results : Of total 1,683 patients with hematologic malionancies 1.545 medical records (91.3%) can be found. Of those, 173 patients (11 2%) had neurologic complications. They were intracranial hemorhage 39 3%, meningeal involvement 23 7%, spinal cord compression 16 8%, intracranial mass 6 9%, and penipheral nerve compression 46%. The prevalences of neurologic complications of acutelymphoblast leukemia (ALL), acute nonlymphocytic leukemia (ANLL), chronic myeloid leukemia (CML), non-Hodgkin's Iymphoma (NHH), Hodgian's disease (HD) and multiple myeloma (MM) were 13.0%, 116%, 16.1% 10.3%, 69% and 9.9.99%, respectively. Excluding intracral hemomonhage, the prevalences of neurologic complications of each type of hematologic malignancy were 8.7%, 1.9%, 4.0%,79.7%, 56% and 9.2% respectively. There were signt association between types of hematologic malionancies and pattems of neurologic comblications / p < 0.00t). Concerming specic complications, intracranial hemorhage was found in 9.9.6% of patients with ANLL; meningeal invokement were found in 7.5% of ALL patients and in 3.7% of NHL patients; and spinal cord compression was common in in patients with multiple myeloma (66%), HD (2.8%) and NHL (2.3%). Conclusion : Neurological complications are not uncommon, but important in patients with hematologic
malignancies. They are significantly associated with specific type of neoplasms. Early diagnosis will bring to proper management and reduce serious morbidity.

Downloads

Download data is not yet available.

References

Anthens JW, Ward JH. Complications of hematopopoietic neoplasm. In : Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN. eds. Wintrobe's Clinical Hematology. 9th ed. Philadelphia : Lea and Febiger, 1993:1808-12.

Meyer RJ, Ferreira PP, Cuttner J, et al. Central nerveous system involvement at presentation in granulocytic leukemia. A prospective cytocentrifuge study. Am J Med 1980;68:691-4.

Stewart DJ, Keating MJ, McCredit KB, et al. Natural history of central nervous system acute leukemia in adult. Cancer 1981;47:184-96.

Litam JP, Cabanillas F, Smith TL, Bodey GP, Freireich EJ. Central nervous system relapse in malignant lymphomas: Rusk factor and implication for prophylaxis. Blood 1979;54:1249-57.

Herman TS, Hammond M, Jones SE, et al. Involvement of central nervous system by non-Hodgkin's lymphoma: The Southwest Oncology Group expirience. Cancer 1979;43:390-7.

Adam RD,Victer M. Intracranial neoplasms. In : Principle of Neurology. 5* ed. New York : McGraw-Hill, 1993:554-98.

Bennett JM, et al. Proprosal for classification of acute leukemia. Br J Haematol 1976;33:451-8.

Rosenberg SA, Berard CW, Brown BW, et al. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma : Summery and description of a Working Formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982;49:2112-35.

Report of the committee on the staging of Hodgkin's Disease. Cancer Res 1966;26:1310-7.

Graus F, Roger LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine 1985;64:16-35.

Barcos M, Lane W, Gomez G, et al. An autopsy study of 1,206 acute and chronic leukemias (1958 to 1982). Cancer 1987;60:827-37.

Hug V, Keating M, McCredie K, et al. Clinical course and respond to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count. Cancer 1983;52:773-9.

Walker RW. Neurologic complications of leukemia. Neurol Clin 1991;9:989-99.

Ginsberg LE, Leeds NE. Neuroradiology of leukemia. AJR 1995;165:525-34.

Nieri RL, Burgert EO, Groover RV. Central nervous system complications of leukemia: A review. Mayo Clin Proc 1968;43:70-9.

Hutter JJ, Favosa BE, Nelson M. Non-Hodgkin's lymphoma in children correlation of CNS disease with initial presentation. Cancer 1975;36:2132-7.

Recht L, Straus DJ, Cirrincione C, Thaler HT, Posner JB. Central nervous system metastasis from non-Hodgkin's lymphoma : treatment and prophylaxis. Am J Med 1988;84:425-35.

Ziegler JL, Bluming AZ, Morrow RH, Fass L, Carbone PP. Central nervous system involvement in Burkitt's lymphoma. Blood 1970;36:718-28.

Law IP, Dick FR, Bloom J, et al. Involvement of the central nervous system in non-Hodgkin's lymphoma. Cancer 1975;36:225.

Mead GM, Kennedy P, Smith JL, et al. Involvement of the central nervous system by non-Hodgkin's in adults. A review of 36 cases. QJM 1986;231:699-714.

Blaney SM, Balis FM, Poplack DG. Current pharmacological treatment approaches to central nervous system leukemia. Drug 1991;41:702-16.

Wiernick PH, Diagnosis and treatment of adult acute myelocytic leukemia. In : Wiernick PH, Canellos GP, Dutcher JP, et al. eds. Neoplastic disease of blood 3rd ed. New York : Churchill Livingstone Inc, 1996:331-51.

Moran CC, Anderson CC, Caldemyer KS, et al. Meningeal Myelomatosis: CT and MR appearances. AJNR 1995;16:1501-3.

Bergevin PR. Central nerveous system leukemia. NY State J Med 1975;Feb:367-71.

Dawson DM, Rosenthal DS, Moloney WC, Neurological complications of acute leukemia in adults : Changing rate. Ann Intern Med 1973;79:541-544

Bigner SH, Cerebrospinal fluid cytology : Current status and diagnostic applications. J Neuropathol Exp Neurol 1992;51:235-44.

Recht L. Neurologic complications of systemic lymphoma. Neurol Clin 1991;9:1001-15.

Laing RJ, Jakubowski J, Kunkler IH, Hancock BW. Primary spinal presentation of non-Hodgkin's lymphoma. Spine 1992;17:117-20.

Mullins GM, Flynn JP, El-Mahdi AM, McQueen D, Owens AH. Malignant lymphoma of the spinal epidural space. Ann Intern Med 1971;74:416-23.

Silverstein A, Doniger AE. Neurologic complications in myelomatosis. Arch Neurol 1963;9:534-40

Pertursson SR. Boggs DR. Spinal cord involvement in leukemia. Cancer 1981;47:346-50.

Parekh HC, Sharma RR, Lynch PG, Keogh AS, Prabher SS. Primary cerebral lymphoma : report of 24 patients and review of literature. Br J Neurosurg 1992,563-73.

Downloads

Published

2018-12-30

Issue

Section

นิพนธ์ต้นฉบับ (Original article)